Holen Sie sich die Stockscreener-App
0.28
0.00%
0.00
Handel nachbörslich:
.29
0.010
+3.57%
Oncology Institute Inc Aktie (TOI) Neueste Nachrichten
The Oncology Institute Announces Third Quarter 2024 Earnings Release Date and Conference Call - ForexTV.com
The Oncology Institute Announces Third Quarter 2024 Earnings Release Date and Conference Call - GlobeNewswire Inc.
Cancer Care - WellSpan Health
GlycoMimetics Announces National Cancer Institute Phase 2/3 Study of Uproleselan Did Not Meet Primary Endpoint - Business Wire
The Oncology Institute Joins Lantern's Cancer Care Network of Excellence - The Manila Times
The Oncology Institute Joins Lantern’s Cancer Care Network of Excellence - GlobeNewswire
The American Journal of Managed Care® and The Oncology - GlobeNewswire
The American Journal of Managed Care® and The Oncology Institute to Co-Host Symposium for Value-Based Cancer Care - StockTitan
TOIIWThe Oncology Institute, Inc. Warrant Latest Stock News & Market Updates - StockTitan
The Oncology Institute of Hope & Innovation Launches Oregon Market - GlobeNewswire
IGI Announces CRADA with National Cancer Institute to Test - GlobeNewswire
Cancer Care | Plantation - Baptist Health South Florida
The Oncology Institute Announces CFO Changes - Marketscreener.com
Logos Global Management LP Takes $14.30 Million Position in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) - Defense World
Promising Progress in Oncology as Cancer Deaths Decline and Research Grows - Baystreet.ca
Nomic® and Parker Institute for Cancer Immunotherapy (PICI) Launch Large-Scale Protein Profiling to Investigate Immunotherapy Responses in RADIOHEAD Study - Business Wire
Farallon Capital Management LLC Sells 729,200 Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) - MarketBeat
The Oncology Institute announces chief financial officer transition - Yahoo Finance
Circassia Pharmaceuticals Announces Share Buyback - TipRanks
Circassia Pharmaceuticals Announces Strong H1 2024 Results - TipRanks
Indian Oil Corp. shares up 0.76% as Nifty gains - The Economic Times
The Oncology Institute appoints new CFO - Investing.com
Oncology Institute Announces CFO Transition and Strategic Growth Plan - TipRanks
The Oncology Institute Announces CFO Transition - GlobeNewswire
Cardinal Health to acquire Integrated Oncology Network for $1.12B - HealthLeaders Media
Ionis Plans $500M Public Offering - San Diego Business Journal
Itau Unibanco Holding S.A. Buys Shares of 767 Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) - Defense World
Renaissance Technologies LLC Purchases 69,800 Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) - Defense World
ORIX Co. (NYSE:IX) Shares Purchased by American Century Companies Inc. - Defense World
DRW Securities LLC Makes New $2.43 Million Investment in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) - MarketBeat
Victory Capital Management Inc. Sells 307 Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) - Defense World
The Oncology Institute, Inc. (TOI) Reports Q2 Loss, Misses Revenue Estimates - MSN
Granite Investment Partners LLC Decreases Stock Holdings in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) - Defense World
Cardinal Health to acquire Integrated Oncology Network for $1.12 billion By Reuters - Investing.com
Cardinal Health acquiring Integrated Oncology Network for $1.1B - Fierce healthcare
Cardinal to acquire Integrated Oncology Network for $1.12B in cash - Axios
Cardinal Health to acquire Integrated Oncology Network for $1.1B - Modern Healthcare
Cardinal Health to acquire Integrated Oncology Network for $1.12 billion - PharmaLive
Cardinal Health expands with $1.115B ION acquisition - Investing.com
Cardinal Health to acquire Integrated Oncology Network for $1.115B in cash - TipRanks
Cardinal Health to acquire Integrated Oncology Network, a physician-led independent community oncology network - StockTitan
Oncolytics Biotech (NASDAQ:ONCY) Stock Rating Reaffirmed by HC Wainwright - MarketBeat
Oncolytics Biotech reports positive results from breast cancer study | 2024-09-19 | Investing News - Stockhouse Publishing
Oscar Health stock soars to 52-week high, hits $23.45 - Investing.com
Oncolytics Phase 2 breast cancer data ‘compelling, says H.C. Wainwright - TipRanks
Oncolytics Biotech Inc - Baystreet.ca
Oncolytics Biotech’s Promising Breast Cancer Study - TipRanks
State of New Jersey Common Pension Fund D Sells 26,498 Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) - Defense World
Share price of Indian Oil Corp. falls as Nifty strengthens - The Economic Times
SciTech Development, Inc. Announces Receipt of Drug Supply From The National Cancer Institute (NCI) - BioSpace
BayCare Cancer Institute Breaks Ground on First Proton Therapy Center in Tampa Bay Area - Yahoo Finance
Biosplice Therapeutics Announces Initiation of Acute - GlobeNewswire
Oncology Institute Inc (TOI) Stock: A Year of Highs and Lows in the Market - The InvestChronicle
Florida Cancer Specialists & Research Institute Launches Partnership with Paradigm Health, Inc. to Expand Patient Access to Lifesaving Clinical Trials - PR Newswire
Ratios Revealed: Decoding Oncology Institute Inc (TOI)’s Financial Health - The Dwinnex
Oncology Institute (NASDAQ:TOI) Shares Down 1.7% - Defense World
How To Buy The Oncology Institute, Inc. Stock Online in August 2024 - Traders Union
McKesson Signs Agreement to Acquire Controlling Interest in Florida Cancer Specialists & Research Institute’s Core Ventures - Business Wire
Oncology Institute Inc (TOI)’s Day in Review: Closing at 0.34, Down by -3.66 - The Dwinnex
Florida Cancer Specialists & Research Institute Expands Access to Advanced Gynecologic Oncology Treatments - Yahoo Finance
Was there any good news for Oncology Institute Inc (TOI) stock in the last session? - US Post News
Oncology Institute Inc (TOI) Stock: A Year of Market Fluctuations - The InvestChronicle
Balance Sheet Dive: Oncology Institute Inc (TOI)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
The Oncology Institute, Inc. (NASDAQ:TOI) Q2 2024 Earnings Call Transcript - Insider Monkey
4.74%
1.92%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):